Much data suggests intersecting activities between the adipokine apelin (APLN) and the pathologic processes of obesity and osteoarthritis (OA), with APLN modulating cartilage, synovium, bone, and various immune cell activities. The gene discussed is APLN; the disease is obesity due to melanocortin 4 receptor deficiency.